
Ondra Health Review
Best for: Cost-sensitive patients who want the lowest compounded-GLP-1 monthly cost and are willing to commit quarterly.
Ondra Health is a 50-state compounded-GLP-1 telehealth platform on a flat "same price all doses" model, with no brand-name or peptide add-ons. It names five prescribing physicians and five 503A pharmacy partners — more transparency than the typical compounded provider — plus a displayed LegitScript seal and HIPAA claim. Aggressive quarterly pricing brings semaglutide to roughly $93/mo and tirzepatide to about $166/mo.
What the monthly price covers
Medication
Included
Provider visits
Not disclosed
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Ondra Health is one of the most affordable GLP-1 options on the market.
Ondra Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $93/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Ondra Health
Each dimension is scored algorithmically from Ondra Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.8/10At $93/mo, Ondra Health runs about 45% below the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.6/10Ondra Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.7/10Online intake and platform experience; 8 platform features disclosed.
Trust & Safety15%
8.3/10Key details fully confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-06).
Accessibility10%
7.8/10Ondra Health treats patients in all 50 states.
Support10%
5.4/10Ondra Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Ondra Health review
Last checked 2026-06-06- Confirmed current pricing across 4 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications Ondra Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check Ondra Health's current pricing and active discounts before you decide.
What we like
- Aggressive quarterly pricing — ~$93/mo effective for semaglutide is among the lowest in the segment
- Five provider physicians named — more transparency than typical compounded-GLP-1 platforms
- Five named 503A pharmacy partners disclosed
- LegitScript seal and HIPAA claim displayed
- Licensed in all 50 states
Watch-outs
- No brand-name GLP-1 option (no Wegovy/Zepbound/Mounjaro)
- Corporate physical address not disclosed
- Hallandale pharmacy excluded in 9 states (CA, KS, AR, MI, MN, AL, HI, MS, MA) — routing may vary
- No medical director named
- LegitScript certification number not shown
Ondra Health: the low-cost play for committed compounded-GLP-1 patients
Ondra Health is built around one promise: get your compounded semaglutide or tirzepatide as cheaply as possible, as long as you're willing to commit. If you pay quarterly, the effective monthly cost drops to roughly $93 for semaglutide — among the lowest in the segment and well under the category median of about $170. The trade-off is simple and you should know it going in: there is no brand-name option here, no peptide add-ons, and the deepest discounts only show up when you pay for three months at once.
How the 'same price on all doses' pricing actually works
Most compounded providers quietly raise your bill as your dose climbs during titration. Ondra doesn't. Its headline is a flat model — the same monthly price applies across every titration dose within a plan, so a starter dose and a maintenance dose cost the same. Semaglutide runs at its standard monthly rate, or you can prepay a quarter for the much lower effective rate of about $93 a month. Tirzepatide sits higher on both the monthly and quarterly tracks. Medication and free shipping to your door are included in those numbers.
Worth flagging honestly: the quarterly price is where the real savings live. If you pay month-to-month, Ondra is competitive but not dramatically cheaper than rivals. The flat-dose structure is the genuinely patient-friendly part — you won't get punished for moving up the dose ladder.
What's not bundled in
The site is explicit that your treatment is evaluated by an independent licensed provider, but it does not advertise a 'no consult fee' guarantee or bundled labs and coaching. So treat this as a medication-and-shipping price, not necessarily an all-in concierge package. Confirm any evaluation or intake costs before you commit to a quarter.
Medications and how they're dispensed
Ondra is GLP-1-only and compounded-only. You can get compounded semaglutide or compounded tirzepatide — and that's the full menu. There is no Wegovy, Zepbound, or Mounjaro here, and no oral options. If brand-name access or insurance billing matters to you, this is the wrong provider.
Where Ondra stands out is dispensing transparency. It names five 503A pharmacy partners outright — Hallandale Pharmacy, Quaker Community Pharmacy / New Life RX, Strive Pharmacy, VialsRX, and The Pharmacy Hub — rather than hiding behind a vague 'partner network.' That's more than most compounded platforms disclose.
The real differentiator: named clinicians and pharmacies
For a compounded telehealth brand, Ondra is unusually willing to show its work. It names five prescribing physicians — Dr. David Wasef, Dr. Michael Wasef, Dr. Ozita Cooper, Dr. James Teet, and Dr. Frank Suppa — and our verification confirmed all five hold active NPIs, with Dr. Cooper carrying an Obesity Medicine subspecialty and a multi-state license roster. That level of named-provider transparency is rare in this corner of the market and is the single best reason to trust Ondra over an anonymous competitor.
One nuance for the record: clinical services are contracted to Wasef Health, PC, a physician group that also prescribes for several other unrelated DTC brands. That's a standard moonlighting-physician arrangement, not a white-label clone — Ondra has zero pharmacy-partner or corporate-operator overlap with those other brands. It's normal for the industry, but it's why the medical oversight is a contracted network rather than an in-house staff.
Trust, safety, and the gaps to watch
Ondra displays a LegitScript seal and a HIPAA-compliance claim, is licensed in all 50 states, and there are no FDA warning letters on file against it. Combined with the named clinicians and pharmacies, that puts its verification confidence on the higher end for a compounded provider.
- No corporate physical address disclosed — the company is Ondra Health Inc. and reachable at care@ondra.health, but there's no street address listed.
- No named medical director — clinical work runs through a contracted PC rather than a publicly named director of medicine.
- LegitScript certification number isn't shown — the seal is displayed without the verifiable cert number.
- Pharmacy routing varies by state — Hallandale is excluded in nine states (CA, KS, AR, MI, MN, AL, HI, MS, MA), so your medication may come from a different partner depending on where you live.
Who should choose Ondra — and who should skip it
Choose Ondra if you're cost-sensitive, already sold on compounded GLP-1, and confident enough to commit quarterly to unlock the lowest effective price. The flat-dose model and named clinicians make it a sensible pick for a patient who knows they'll stay on treatment for at least a few months.
Skip it if you want a brand-name GLP-1, need insurance billing, prefer month-to-month flexibility without prepaying, or want a named medical director and a disclosed corporate address before you hand over your card. Those are reasonable dealbreakers, and Ondra doesn't clear them.
Bottom line
Ondra Health is a lean, aggressively priced compounded-GLP-1 platform that earns trust the right way — by naming its doctors and pharmacies and staying licensed everywhere — while keeping its menu deliberately narrow. The roughly $93-a-month effective semaglutide rate is genuinely competitive, but you only reach it by paying quarterly and accepting compounded-only, GLP-1-only treatment. For the budget-focused patient who fits that box, it's a strong-value option. For anyone who wants brand access, flexibility, or a fully disclosed corporate footprint, look elsewhere. See our scoring methodology for how we weigh price, transparency, and oversight.
Worth pricing against Telos Rx ($49/month) and bmiMD ($99/month) before you commit — both sit close to Ondra Health on cost and formulation.
Ready to start with Ondra Health?
Starting at $93/month. See current pricing and start your free consultation.
Alternatives to Ondra Health
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Ondra Health review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Ondra Health?
Starting at $93/month. See current pricing and start your free consultation.